Insider Trading & Ownership of Gregory Bailey

Location
Huntsville, AL
Summary
The estimated net worth of Gregory Bailey is at least $19,409,170 dollars as of 21 Apr 2026. Gregory Bailey is the Director of Biohaven Ltd. and owns shares of Biohaven Ltd. (BHVN) stock worth about $15.15M. Gregory Bailey is the Director of Serina Therapeutics, Inc. and owns shares of Serina Therapeutics, Inc. (SER) stock worth about $4.26M.
Signature
/s/ Gregory Bailey
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Gregory Bailey and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Gregory Bailey has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $19,409,170.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Biohaven Ltd. ($15,150,532).
  • Past-year value change for that position: +$3,000,000.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Gregory Bailey

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BHVN Biohaven Ltd. Director $15,150,532 +$3,000,000 +25% 13 Nov 2025
SER Serina Therapeutics, Inc. Director $4,258,638 31 Mar 2026
BHVN Biohaven Pharmaceutical Holding Co Ltd. Director 03 Oct 2022

Insider Transactions Reported by Gregory Bailey:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.